longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Larimar Therapeutics

LRMR

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI
  • Weekly Recap | MOAT.US -0.89%, lighter-volume pullback

    Weekly Review·Sep 19 at 07:40 AM
    MOAT-0.57%
  • Weekly Recap | ARKG.US +13.35%, AI healthcare leads genomics theme

    Weekly Review·Sep 19 at 07:15 AM
    ARKG-2.70%
  • Weekly Recap | Twist Bioscience +31.26%, signs deal with Lilly TuneLab

    Weekly Review·Sep 19 at 06:54 AM
    TWST-4.30%
  • Weekly Recap | RXRX.US +19.69%, most brokers rate it buy

    Weekly Review·Sep 19 at 06:40 AM
    RXRX-3.58%
  • Weekly Recap | Larimar Therapeutics +2.35%, most brokers rate it buy

    Weekly Review·Sep 12 at 06:12 AM
    LRMR-0.92%
  • The S&P Pharmaceutical Index closed up about 5.2%, and the Biotechnology Index rose 2.6%

    Wallstreetcn·Oct 1, 2025 at 08:26 PM
    NVAX-0.55%APLT0.00%
  • The Nasdaq Biotechnology Index rose 2.2%, reaching an intraday high since 2021

    Wallstreetcn·Oct 1, 2025 at 02:12 PM
    REGN-0.82%ARCT-5.08%